Department of Epigenetics, Van Andel Research Institute, Grand Rapids, United States; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Eric H Ma
Department of Metabolism and Nutritional Programming, Van Andel Research Institute, Grand Rapids, United States
Vanessa Wegert
Department of Epigenetics, Van Andel Research Institute, Grand Rapids, United States; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Ryan Sheldon
Metabolomics and Bioenergetics Core, Van Andel Institute, Grand Rapids, United States
Ilaria Panzeri
Department of Epigenetics, Van Andel Research Institute, Grand Rapids, United States; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Klaus Gossens
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Josephine Völker
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Shengru Pang
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
Anna Bremser
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Erez Dror
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Francesca Giacona
Department of Epigenetics, Van Andel Research Institute, Grand Rapids, United States
Sagar Sagar
Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; Department of Medicine II, University Hospital Freiburg, Freiburg, Germany
Michael X Henderson
Department of Neurodegenerative Sciences, Van Andel Research Institute, Grand Rapids, United States
Marco Prinz
Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany; Centre for NeuroModulation (NeuroModBasics), University of Freiburg, Freiburg, Germany; Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
Russell G Jones
Department of Metabolism and Nutritional Programming, Van Andel Research Institute, Grand Rapids, United States
Department of Epigenetics, Van Andel Research Institute, Grand Rapids, United States; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
Chronic high-fat feeding triggers metabolic dysfunction including obesity, insulin resistance, and diabetes. How high-fat intake first triggers these pathophysiological states remains unknown. Here, we identify an acute microglial metabolic response that rapidly translates intake of high-fat diet (HFD) to a surprisingly beneficial effect on metabolism and spatial/learning memory. High-fat intake rapidly increases palmitate levels in cerebrospinal fluid and triggers a wave of microglial metabolic activation characterized by mitochondrial membrane activation and fission as well as metabolic skewing toward aerobic glycolysis. These effects are detectable throughout the brain and can be detected within as little as 12 hr of HFD exposure. In vivo, microglial ablation and conditional DRP1 deletion show that the microglial metabolic response is necessary for the acute effects of HFD. 13C-tracing experiments reveal that in addition to processing via β-oxidation, microglia shunt a substantial fraction of palmitate toward anaplerosis and re-release of bioenergetic carbons into the extracellular milieu in the form of lactate, glutamate, succinate, and intriguingly, the neuroprotective metabolite itaconate. Together, these data identify microglia as a critical nutrient regulatory node in the brain, metabolizing away harmful fatty acids and liberating the same carbons as alternate bioenergetic and protective substrates for surrounding cells. The data identify a surprisingly beneficial effect of short-term HFD on learning and memory.